VUOTO ANTHONY
CIK: 0001222060
Associated companies
Transaction History
| IRMD | ▲ Buy | Option Exercise | 1,751 | — | 12/7/2024 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 1,196 | — | 12/7/2024 | View on chart |
| IRMD | ▼ Sell | Open Market | 2,690 | $151K | 11/6/2024 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 1,036 | — | 12/7/2023 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 1,750 | — | 12/7/2023 | View on chart |
| IRMD | ▼ Sell | Open Market | 2,237 | $89K | 11/13/2023 | View on chart |
| IRMD | ▼ Sell | Open Market | 818 | $33K | 11/10/2023 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 2,037 | — | 12/7/2022 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 1,035 | — | 12/7/2022 | View on chart |
| IRMD | ▼ Sell | Open Market | 1,000 | $29K | 12/5/2022 | View on chart |
| IRMD | ▼ Sell | Open Market | 3,937 | $201K | 2/10/2022 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 2,185 | — | 12/7/2021 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 2,037 | — | 12/7/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 3,690 | $137K | 11/3/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
iRadimed Gets Needham Hold Rating and Conference Participation
Needham initiated coverage on iRadimed with a Hold rating, while the company announced it will speak at the ROTH Healthcare Opportunities Conference. These developments add analyst visibility to the stock, which is currently trading near its 52-week high. The new coverage provides a fresh perspective on the company's position in the medical imaging sector.
iRadimed Gets Needham Hold Rating and Conference Participation. Needham initiated coverage on iRadimed with a Hold rating, while the company announced it will speak at the ROTH Healthcare Opportunities Conference. These developments add analyst visibility to the stock, which is currently trading near its 52-week high. The new coverage provides a fresh perspective on the company's position in the medical imaging sector.